Raymond James & Associates’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$40.6M Sell
3,837,536
-182,442
-5% -$1.76M 0.02% 512
2024
Q2
$33.2M Buy
4,019,978
+515,651
+15% +$4.31M 0.02% 549
2024
Q1
$29.8M Buy
3,504,327
+1,641,715
+88% +$13.7M 0.02% 596
2023
Q4
$15.3M Buy
1,862,612
+3,941
+0.2% +$32.5K 0.01% 857
2023
Q3
$15.5M Sell
1,858,671
-211,551
-10% -$1.76M 0.01% 797
2023
Q2
$17.3M Sell
2,070,222
-67,813
-3% -$579K 0.01% 771
2023
Q1
$17.4M Buy
2,138,035
+95,535
+5% +$762K 0.02% 744
2022
Q4
$16.3M Buy
2,042,500
+37,556
+2% +$256K 0.02% 755
2022
Q3
$12.2M Buy
+2,004,944
New +$13M 0.01% 860

Other funds holding HLN

Raymond James & Associates's HLN Position: Q3 2024 in Review

Raymond James & Associates reduced its Haleon (HLN) stake by 4.5% in Q3 2024, selling an estimated $1.76M and leaving 3,837,536 shares worth $40.6M. The position accounts for 0.02% of the portfolio, ranked #512.

Raymond James & Associates first reported a position in HLN in Q3 2022 and has held it in 9 quarters since. 588 funds tracked by Wall St. Rank hold HLN as of Q3 2024.

  • Raymond James & Associates held 3,837,536 shares of Haleon worth $40.6M as of Q3 2024.
  • Raymond James & Associates sold 182,442 Haleon shares in Q3 2024, an estimated $1.76M.
  • Haleon made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #512 holding.
  • Raymond James & Associates first reported a position in Haleon in Q3 2022 and has held it in 9 quarters since.
  • 588 funds tracked by Wall St. Rank held Haleon as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.